Apart from il5, expression of these gene transcripts was significantly reduced with GM-1111 treatment (p<0.001 to 0.05), suggesting that GM-1111 is effective in reducing key inflammatory cells and cytokines involved in allergy and Th2-mediated adaptive immune signaling. The gene discussed is IL5; the disease is Allergy.